Delivery Order SPE2DB20D2104-SPE2DB22FT29P
- Not listed
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order valued at $2,613.14 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a period of performance through May 31, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,951.97 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of RABAVERT Rabies Vaccine with diluents, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,606, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,737.27 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. No set-aside designations were used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $20,290.20. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 9, 2022 by the Defense Logistics Agency (DLA). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The $48,309.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,002.20 firm fixed-price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Rabavert Rabies Vaccine with diluents to the Defense Logistics Agency (DLA). The $43,479.00 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 25, 2022 with a completion date of July 26, 2022. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT29PDelivery Order
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $2,898.60, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price delivery order with a period of performance ending on July 19, 2022. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities. This IDC serves as a primary vehicle for the company to support the healthcare needs of the Department of Defense and other federal agencies. The current $2,898.60 delivery order is one of many issued under this larger IDC contract. There is no set-aside designation noted for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/18/22 |